Oscar Health Inc. (NYSE:OSCR) saw a downside of -1.28% to close Tuesday at $6.92 after subtracting -$0.09 on the day. The 5-day average trading volume is 1,307,420 shares of the company’s common stock. It has gained $7.76 in the past week and touched a new high 1 time within the past 5 days. An average of 1,806,265 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,802,646.
OSCR’s 1-month performance is -13.17% or -$1.09 on its low of $6.72 reached on 08/15/23. The company’s shares have touched a 52-week low of $2.05 and high of $9.89, with the stock’s rally to the 52-week high happening on 06/13/23. YTD, OSCR has achieved 181.30% or $4.46 and has reached a new high 34 times. However, the current price is down -30.03% from the 52-week high price.
Insider Transactions
OSCR stock investors last saw insider trading activity on Aug 17.Alphabet Inc. (10% Owner) most recently sold 6,500,000 shares at $8.08 per share on Aug 17. This transaction cost the insider $52,526,500. President of Technology & CTO, Schlosser Mario, sold 235,000 shares at a price of $6.91 on Aug 15. Then, on Jun 06, Chief Transformation Officer Blackley Richard Scott sold 23,955 shares at a price of $8.39 per share. This transaction amounted to $201,093.
Valuation Metrics
OSCR stock has a beta of 1.03. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.31 while the price-to-book (PB) in the most recent quarter is 1.60, with the price to cash flow ratio at 10.00.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.31, while the total debt to equity was 0.31. The firm’s gross profit as reported stood at -$610.08 million against revenue of $3.96 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -622.22% to -$15.53 million, while revenue of -$39.77 million was -156.08% off the previous quarter. Analysts expected OSCR to announce -$0.23 per share in earnings in its latest quarter, but it posted -$0.07, representing a 69.60% surprise. EBITDA for the quarter stood at more than -$5.46 million. Shareholders hold equity totaling $221.91 million.
Let’s look briefly at Oscar Health Inc. (OSCR) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 39.37% to suggest the stock is trending Neutral, with historical volatility in this time period at 76.37%.
The stock’s 5-day moving average is $7.13, reflecting a -8.47% or -$0.64 change from its current price. OSCR is currently trading -13.39% above its 20-day SMA, +8.13% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -24.78% and SMA200 by+101.16%.
Stochastic %K and %D was 16.76% and 21.92% and the average true range (ATR) pointed at 0.46. The RSI (14) points at 41.28%, while the 14-day stochastic is at 10.81% with the period’s ATR at 0.46. The stock’s 9-day MACD Oscillator is pointing at -0.19 and -0.24 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Oscar Health Inc. (NYSE: OSCR), BofA Securities upgraded it to a Neutral rating. They previously had an Underperform rating on the stock. Analysts offering their rating for OSCR stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate OSCR as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.
What is OSCR’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $5.00 and a high of $12.00, with their median price target at $8.50. Looking at these predictions, the average price target given by analysts is for Oscar Health Inc. (OSCR) stock is $8.43.
